224 related articles for article (PubMed ID: 15753006)
21. Identification of HPV variants.
Cason J; Bible J; Mant C
Methods Mol Med; 2005; 119():15-25. PubMed ID: 16350393
[TBL] [Abstract][Full Text] [Related]
22. Diseases caused by human papillomaviruses (HPV).
Handisurya A; Schellenbacher C; Kirnbauer R
J Dtsch Dermatol Ges; 2009 May; 7(5):453-66; quiz 466, 467. PubMed ID: 19302229
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus in head and neck cancer: molecular biology and clinicopathological correlations.
Szentirmay Z; Pólus K; Tamás L; Szentkuti G; Kurcsics J; Csernák E; Tóth E; Kásler M
Cancer Metastasis Rev; 2005 Jan; 24(1):19-34. PubMed ID: 15785870
[TBL] [Abstract][Full Text] [Related]
24. Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions.
Andersson K; Waterboer T; Kirnbauer R; Slupetzky K; Iftner T; de Villiers EM; Forslund O; Pawlita M; Dillner J
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):189-95. PubMed ID: 18199724
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus: its identity and controversial role in oral oncogenesis, premalignant and malignant lesions (review).
Campisi G; Panzarella V; Giuliani M; Lajolo C; Di Fede O; Falaschini S; Di Liberto C; Scully C; Lo Muzio L
Int J Oncol; 2007 Apr; 30(4):813-23. PubMed ID: 17332919
[TBL] [Abstract][Full Text] [Related]
26. Genomic diversity of human papillomaviruses (HPV) and clinical implications: an overview in adulthood and childhood.
Mammas IN; Spandidos DA; Sourvinos G
Infect Genet Evol; 2014 Jan; 21():220-6. PubMed ID: 24291228
[TBL] [Abstract][Full Text] [Related]
27. Prediction of conserved microRNAs from skin and mucosal human papillomaviruses.
Gu W; An J; Ye P; Zhao KN; Antonsson A
Arch Virol; 2011 Jul; 156(7):1161-71. PubMed ID: 21442230
[TBL] [Abstract][Full Text] [Related]
28. Comparative transforming potential of different human papillomaviruses associated with non-melanoma skin cancer.
Massimi P; Thomas M; Bouvard V; Ruberto I; Campo MS; Tommasino M; Banks L
Virology; 2008 Feb; 371(2):374-9. PubMed ID: 17997466
[TBL] [Abstract][Full Text] [Related]
29. High prevalence of high-risk oncogenic human papillomaviruses harboring atypical distribution in women of childbearing age living in Libreville, Gabon.
Si-Mohamed A; Ndjoyi-Mbiguino A; Cuschieri K; Onas IN; Colombet I; Ozouaki F; Goff JL; Cubie H; Bélec L
J Med Virol; 2005 Nov; 77(3):430-8. PubMed ID: 16173023
[TBL] [Abstract][Full Text] [Related]
30. [Virological and carcinogenic aspects of HPV].
Prétet JL; Charlot JF; Mougin C
Bull Acad Natl Med; 2007 Mar; 191(3):611-23; discussion 623. PubMed ID: 18072657
[TBL] [Abstract][Full Text] [Related]
31. The natural history of human papillomavirus infections of the mucosal epithelia.
Chow LT; Broker TR; Steinberg BM
APMIS; 2010 Jun; 118(6-7):422-49. PubMed ID: 20553526
[TBL] [Abstract][Full Text] [Related]
32. Phylogenetic analysis of beta-papillomaviruses as inferred from nucleotide and amino acid sequence data.
Gottschling M; Köhler A; Stockfleth E; Nindl I
Mol Phylogenet Evol; 2007 Jan; 42(1):213-22. PubMed ID: 16935527
[TBL] [Abstract][Full Text] [Related]
33. Epidemiologic risk profile of infection with different groups of human papillomaviruses.
Chan PK; Ho WC; Wong MC; Chang AR; Chor JS; Yu MY
J Med Virol; 2009 Sep; 81(9):1635-44. PubMed ID: 19623668
[TBL] [Abstract][Full Text] [Related]
34. Development of a general-primer-PCR-reverse-line-blotting system for detection of beta and gamma cutaneous human papillomaviruses.
Brink AA; Lloveras B; Nindl I; Heideman DA; Kramer D; Pol R; Fuente MJ; Meijer CJ; Snijders PJ
J Clin Microbiol; 2005 Nov; 43(11):5581-7. PubMed ID: 16272490
[TBL] [Abstract][Full Text] [Related]
35. Complete genotyping of mucosal human papillomavirus using a restriction fragment length polymorphism analysis and an original typing algorithm.
Nobre RJ; de Almeida LP; Martins TC
J Clin Virol; 2008 May; 42(1):13-21. PubMed ID: 18304866
[TBL] [Abstract][Full Text] [Related]
36. Molecular diagnosis of human papillomavirus (HPV) infections.
Molijn A; Kleter B; Quint W; van Doorn LJ
J Clin Virol; 2005 Mar; 32 Suppl 1():S43-51. PubMed ID: 15753011
[TBL] [Abstract][Full Text] [Related]
37. Shared and persistent asymptomatic cutaneous human papillomavirus infections in healthy skin.
Hsu JY; Chen AC; Keleher A; McMillan NA; Antonsson A
J Med Virol; 2009 Aug; 81(8):1444-9. PubMed ID: 19551818
[TBL] [Abstract][Full Text] [Related]
38. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
Jenkins D
Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of human papillomavirus types in cervical and oral cancers in central India.
Gheit T; Vaccarella S; Schmitt M; Pawlita M; Franceschi S; Sankaranarayanan R; Sylla BS; Tommasino M; Gangane N
Vaccine; 2009 Jan; 27(5):636-9. PubMed ID: 19056450
[TBL] [Abstract][Full Text] [Related]
40. Hybridization assay performed at ambient temperature for typing high-risk human papillomaviruses.
Brukner I; El-Ramahi R; Sawicki J; Gorska-Flipot I; Krajinovic M; Labuda D
J Clin Virol; 2007 Jun; 39(2):113-8. PubMed ID: 17482870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
